- 全部删除
您的购物车当前为空
CHMFL-FLT3-122 是一种强效口服 FLT3 激酶抑制剂,用于治疗 FLT3-ITD 阳性急性髓性白血病。CHMFL-FLT3-122能显著抑制 MV4-11细胞异种移植模型(50 mg/kg)的肿瘤生长,且在体内无明显毒性。

CHMFL-FLT3-122 是一种强效口服 FLT3 激酶抑制剂,用于治疗 FLT3-ITD 阳性急性髓性白血病。CHMFL-FLT3-122能显著抑制 MV4-11细胞异种移植模型(50 mg/kg)的肿瘤生长,且在体内无明显毒性。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 488 | In stock | |
| 5 mg | ¥ 1,160 | In stock | |
| 10 mg | ¥ 1,730 | In stock | |
| 25 mg | ¥ 2,920 | In stock |
CHMFL-FLT3-122 相关产品
| 产品描述 | CHMFL-FLT3-122 is a potent and orally available FLT3 kinase inhibitor used to treat FLT3-ITD positive acute myeloid leukemia. CHMFL-FLT3-122 significantly suppressed the tumor growth in MV4-11 cell inoculated xenograft model (50 mg/kg) without exhibiting obvious toxicity in vivo. |
| 别名 | CHMFLFLT3122, CHMFL FLT3 122 |
| 分子量 | 471.55 |
| 分子式 | C26H29N7O2 |
| CAS No. | 1839150-56-9 |
| Smiles | NC1=C2C(N(N=C2C3=CC=C(OC4=CC=CC=C4)C=C3)[C@H]5CN(C(CN(C)C)=O)CCC5)=NC=N1 |
| 密度 | 1.33 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | 1eq. HCl: 90 mg/mL (190.86 mM), Sonication is recommended. DMSO: 90 mg/mL (190.86 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
1eq. HCl/DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容